iomeprol has been researched along with Delayed Effects, Prenatal Exposure in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intravenous daily dosing for 4 weeks showed that iomeprol was well tolerated at doses as high as the maximum dose anticipated for clinical use." | 1.29 | Toxicological safety assessment of iomeprol, a new X-ray contrast agent. ( de Haën, C; Luzzani, F; Morisetti, A; Tirone, P, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morisetti, A | 1 |
| Tirone, P | 1 |
| Luzzani, F | 1 |
| de Haën, C | 1 |
1 other study available for iomeprol and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
Topics: Abnormalities, Drug-Induced; Animals; Antibody Formation; Antigens; Contrast Media; Dogs; Drug Toler | 1994 |